You are here

Home

Treatments

12 key symptoms define long Covid, new study shows, bringing treatments closer

Thu, 2023-05-25 20:47 — mike kraft
Government-funded study creates first symptom-based long Covid definition, a step toward finding treatments | CNN After more than two years and an investment of nearly $1.2 billion, researchers say they’ve come up with a list of 12 symptoms that can reliably classify someone as having long Covid, a working definition that should accelerate research into the disabling condition. CNN
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Government
Health
Pandemics
Public Attitudes
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

COVID pill Paxlovid gets full FDA approval after more than a year of emergency use

Thu, 2023-05-25 20:42 — mike kraft
COVID pill Paxlovid gets full FDA approval after more than a year of emergency use U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid. Thursday's action means the drug has now been fully vetted by the U.S. government and can remain on the market indefinitely. Millions of Americans have received Paxlovid since it was granted emergency authorization in late 2021. It’s become the go-to treatment for adults and older children. The FDA’s approval is only for adults who are at high risk of hospitalization or death from COVID-19. The drug is still available for children under emergency use. AP NEWS
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Government
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report

Cognitive behavioral therapy reduces severe fatigue in long-COVID patients --Dutch study

Tue, 2023-05-09 23:25 — mike kraft
Cognitive behavioral therapy reduces severe fatigue in long-COVID patients Cognitive behavioral therapy lessens fatigue and improves concentration among long-COVID patients. CIDRAP
Country / Region Tags: 
Europe
Global
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

China's CanSinoBIO's inhaled COVID booster reported stronger against BA.1 Omicron subvariant than Sinovac shot

Tue, 2023-05-09 14:21 — mike kraft
CanSinoBIO's inhaled COVID booster stronger against BA.1 Omicron subvariant than Sinovac shot Chinese vaccine firm CanSino Biologic's inhalation-based candidate elicited a better antibody response as a booster against the BA.1 Omicron sub-variant than Sinovac's shot, but the antibody level dropped in months, clinical trial data showed. Reuters R
Country / Region Tags: 
China
Global
General Topic Tags: 
COVID-19
Treatments
Disease Prevention
Medical Testing
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Opinion: The Covid-19 emergency is ending. It’s time for the patient to leave the hospital

Tue, 2023-05-09 14:06 — mike kraft
Dr. Sanjay Gupta: The Covid-19 emergency is ending. It's time for the patient to leave the hospital | CNN After more than three very long years, it's finally happening: The Covid-19 pandemic is ending, at least in the formal sense, both in this country and abroad. This moment is not being marked with parades or big parties but rather with the flourishes of two administrative pens. On Friday, the World Health Organization announced that Covid-19 no longer constitutes a Public Health Emergency of International Concern, and this Thursday, the United States is set to end its own public health emergency declaration. Dr.
Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Government
Health
Medical Personnel
Pandemics
Policy
Public Health
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Analysis: Research into treating long COVID is stuck

Mon, 2023-05-08 13:42 — mike kraft
Long COVID Treatment Research Is Stuck in a Frustrating Catch-22 Patients are feeling abandoned, for good reason. Liz Highleyman Slate Magazine

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Government
Health
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Analysis
Problem

Analysis: Failures in achieving COVID-19 vaccine equity

Fri, 2023-05-05 21:11 — mike kraft
Cascading failures in COVID-19 vaccine equity Ethical analysis should encompass upstream decisions and their downstream consequences Science

Country / Region Tags: 
Africa
Asia
Global
Latin America
Middle East
United Nations
United States
General Topic Tags: 
COVID-19
Treatments
Demographics
Disease
Disease Prevention
Government
Pandemics
Public Health
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

WHO releases strategy paper on COVID disease management and long-term disease prevention

Thu, 2023-05-04 14:55 — mike kraft
From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic The updated two-year strategy builds on the objectives of the 2022 SPRP and supports countries as they are working to transition their critical emergency response activities to longer-term sustained COVID-19 disease prevention, control and management.
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Contagion
Disease Prevention
Government
Health
Medical Personnel
Mutations
Pandemics
Policy
Public Health
Science
Social behavior
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

U.S. FDA approves first RSV vaccine, a long-sought scientific achievement

Wed, 2023-05-03 17:24 — mike kraft
FDA approves first RSV vaccine, a long-sought scientific achievement The FDA has approved the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making. Helen Branswell STAT

 

... The product, GSK’s Arexvy, was approved for adults ages 60 and older.

Country / Region Tags: 
United States
General Topic Tags: 
Treatments
Disease
Disease Prevention
Government
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

After COVID and drug shortages, EU revamps drug laws

Thu, 2023-04-27 14:09 — mike kraft
Explainer: After COVID and drug shortages, EU revamps drug laws The EU is revamping laws governing the 136 billion euro ($148 billion) pharmaceuticals industry aimed at reviving investment and boosting access to affordable drugs at a time when health budgets have been drained by the costs of treating COVID-19. Maggie Fick Reuters

...

Country / Region Tags: 
Europe
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Public Health
Research
Science
Vaccinations
Economics
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.685 seconds.